M. Kane

1.9k total citations
40 papers, 1.4k citations indexed

About

M. Kane is a scholar working on Epidemiology, Hepatology and Health. According to data from OpenAlex, M. Kane has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Hepatology and 10 papers in Health. Recurrent topics in M. Kane's work include Hepatitis B Virus Studies (20 papers), Hepatitis Viruses Studies and Epidemiology (13 papers) and Vaccine Coverage and Hesitancy (10 papers). M. Kane is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis Viruses Studies and Epidemiology (13 papers) and Vaccine Coverage and Hesitancy (10 papers). M. Kane collaborates with scholars based in United States, Switzerland and Belgium. M. Kane's co-authors include Lone Simonsen, Jennifer Lloyd, A. Kane, Michel Zaffran, A. Meheus, Pierre Van Damme, Brittany L. Murphy, Gary C. Schatz, Charles A. Schable and William L. Heyward and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

M. Kane

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kane United States 15 769 762 452 208 73 40 1.4k
Shigui Yang China 26 1.2k 1.6× 561 0.7× 741 1.6× 143 0.7× 141 1.9× 101 2.1k
Elisabetta Franco Italy 20 1.3k 1.7× 943 1.2× 657 1.5× 264 1.3× 68 0.9× 113 2.0k
Rosa Coppola Italy 22 998 1.3× 875 1.1× 329 0.7× 145 0.7× 81 1.1× 65 1.7k
Dean F. Echenberg United States 11 899 1.2× 347 0.5× 582 1.3× 111 0.5× 61 0.8× 17 1.3k
Baudouin Standaert Belgium 24 503 0.7× 459 0.6× 866 1.9× 506 2.4× 61 0.8× 101 1.7k
Maureen Birmingham Switzerland 18 489 0.6× 244 0.3× 779 1.7× 355 1.7× 73 1.0× 29 1.5k
Sybil Tasker United States 20 827 1.1× 218 0.3× 934 2.1× 94 0.5× 104 1.4× 39 1.8k
Dwip Kitayaporn Thailand 24 812 1.1× 137 0.2× 895 2.0× 83 0.4× 265 3.6× 56 1.6k
Francisco Averhoff United States 27 1.9k 2.4× 1.4k 1.8× 611 1.4× 522 2.5× 80 1.1× 91 2.5k
Saleem Kamili United States 31 1.7k 2.2× 3.1k 4.1× 1.4k 3.0× 102 0.5× 102 1.4× 118 3.6k

Countries citing papers authored by M. Kane

Since Specialization
Citations

This map shows the geographic impact of M. Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kane more than expected).

Fields of papers citing papers by M. Kane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kane. The network helps show where M. Kane may publish in the future.

Co-authorship network of co-authors of M. Kane

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kane. A scholar is included among the top collaborators of M. Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kane. M. Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kane, M.. (2015). Labour Rents, Arm’s Length Transfer Pricing and Intangibles: Still Searching for a Solution to the BEPS. Bulletin for international taxation. 69(6/7). 10 indexed citations
3.
Kane, M., et al.. (2013). The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization. Vaccine. 31. J15–J20. 37 indexed citations
4.
Raben, David, M. Kane, Lynne Bemis, et al.. (2005). Maturing Toxicity and Outcomes of a Phase I Trial of Concurrent, Daily Gefitinib and Radiation or Chemoradiation for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN). International Journal of Radiation Oncology*Biology*Physics. 63. S370–S371. 1 indexed citations
5.
Fitzsimons, David W., Pierre Van Damme, Nedret Emiroğlu, et al.. (2002). Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the Newly Independent States. Vaccine. 20(11-12). 1475–1479. 10 indexed citations
6.
Kane, M., et al.. (2002). The case for childhood immunization.. 9 indexed citations
7.
Hall, A., M. Kane, C. Roure, & A. Meheus. (1999). Multiple sclerosis and hepatitis B vaccine? Meeting report. 17. 2473–2475. 7 indexed citations
8.
Kane, M.. (1998). Commentary: Public perception and the safety of immunization. Vaccine. 16. S73–S75. 20 indexed citations
9.
Kane, M.. (1998). Unsafe injections.. PubMed. 76(1). 99–100. 6 indexed citations
10.
Damme, Pierre Van, et al.. (1997). Integration of hepatitis B vaccination into national immunisation programmes. BMJ. 314(7086). 1033–1033. 115 indexed citations
11.
Kane, M., M J Alter, Rafael Esteban, & Mario Rizzetto. (1993). Role of screening in prevention and treatment.. Gut. 34(2 Suppl). S45–S47. 2 indexed citations
12.
Kane, M.. (1993). Progress on the control of hepatitis B infection through immunisation.. Gut. 34(2 Suppl). S10–S12. 41 indexed citations
13.
Mahoney, Frank, et al.. (1993). Effect of a Hepatitis B Vaccination Program on the Prevalence of Hepatitis B Virus Infection. The Journal of Infectious Diseases. 167(1). 203–207. 45 indexed citations
14.
Morens, David M., et al.. (1991). Evaluation of enzyme immunoassay (EIA) as a screening method for hepatitis B markers in an open population. Epidemiology and Infection. 107(3). 673–684. 10 indexed citations
15.
Margolis, Harold S., Gary C. Schatz, & M. Kane. (1990). Development of recommendations for control of hepatitis B virus infections: the role of cost analysis. Vaccine. 8. S81–S85. 20 indexed citations
16.
Kane, M., et al.. (1990). [Hepatitis B vaccine: a new force against pandemic diseases].. PubMed. 11(2). 165–8. 2 indexed citations
17.
Bradley, Daniel W., A. G. Andjaparidze, Edwin H. Cook, et al.. (1988). Aetiological Agent of Enterically Transmitted Non-A, Non-B Hepatitis. Journal of General Virology. 69(3). 731–738. 106 indexed citations
18.
Williams, Charles A., et al.. (1987). Hepatitis B virus transmission in a public school: effects of mentally retarded HBsAG carrier students.. American Journal of Public Health. 77(4). 476–478. 5 indexed citations
20.
Reingold, Arthur, M. Kane, Brittany L. Murphy, et al.. (1982). Transmission of Hepatitis B by an Oral Surgeon. The Journal of Infectious Diseases. 145(2). 262–268. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026